X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-12 | RGNX | Mills Kenneth T. | Dir | S - Sale+OE | $7.91 | -20,602 | 475,103 | -4% | -$163,046 | |||||
| D | 2024-10-01 | RGNX | Karabelas Argeris N | Dir | S - Sale+OE | $10.11 | -10,000 | 11,286 | -47% | -$101,052 | |||||
| D | 2024-09-03 | RGNX | Karabelas Argeris N | Dir | S - Sale+OE | $11.56 | -10,000 | 11,286 | -47% | -$115,588 | |||||
| D | 2024-08-01 | RGNX | Karabelas Argeris N | Dir | S - Sale+OE | $13.51 | -10,100 | 11,286 | -47% | -$136,454 | |||||
2024-08-01 | RGNX | Simpson Curran | CEO | S - Sale | $15.00 | -100 | 170,037 | 0% | -$1,500 | ||||||
| D | 2024-07-29 | RGNX | Karabelas Argeris N | Dir | S - Sale+OE | $15.05 | -11,000 | 11,286 | -49% | -$165,495 | |||||
2024-07-29 | RGNX | Simpson Curran | CEO | S - Sale | $15.04 | -9,648 | 170,137 | -5% | -$145,106 | ||||||
| DM | 2024-07-24 | RGNX | Mills Kenneth T. | Dir | S - Sale+OE | $13.88 | -27,590 | 408,035 | -6% | -$382,934 | |||||
| DM | 2024-07-16 | RGNX | Mills Kenneth T. | Dir | S - Sale+OE | $13.77 | -2,410 | 408,035 | -1% | -$33,192 | |||||
| D | 2024-07-01 | RGNX | Karabelas Argeris N | Dir | S - Sale+OE | $11.27 | -10,000 | 11,286 | -47% | -$112,691 | |||||
| D | 2024-05-14 | RGNX | Mills Kenneth T. | Pres, CEO | S - Sale+OE | $15.81 | -15,000 | 408,035 | -4% | -$237,222 | |||||
| D | 2024-04-15 | RGNX | Mills Kenneth T. | Pres, CEO | S - Sale+OE | $18.19 | -15,000 | 408,035 | -4% | -$272,871 | |||||
| D | 2024-03-14 | RGNX | Mills Kenneth T. | Pres, CEO | S - Sale+OE | $21.86 | -15,000 | 408,035 | -4% | -$327,942 | |||||
| D | 2024-03-05 | RGNX | Pakola Steve | Chief Medical Officer | S - Sale+OE | $28.36 | -12,878 | 107,192 | -11% | -$365,220 | |||||
| D | 2024-02-14 | RGNX | Mills Kenneth T. | Pres, CEO | S - Sale+OE | $16.76 | -15,000 | 408,035 | -4% | -$251,349 | |||||
| D | 2024-01-16 | RGNX | Mills Kenneth T. | Pres, CEO | S - Sale+OE | $15.18 | -45,000 | 408,035 | -10% | -$682,992 | |||||
| D | 2024-01-03 | RGNX | Pakola Steve | Chief Medical Officer | S - Sale+OE | $17.39 | -17,237 | 107,192 | -14% | -$299,789 | |||||
| D | 2023-12-19 | RGNX | Mills Kenneth T. | Pres, CEO | S - Sale+OE | $19.69 | -45,000 | 355,289 | -11% | -$885,825 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |